Medical treatments in the short term management of reflux oesophagitis

P Moayyedi, J Santana, M Khan… - Cochrane Database …, 2007 - cochranelibrary.com
Background Oesophagitis arises when reflux of acid from the stomach into the oesophagus
causes mucosal inflammation. It is a common problem and a systematic review on the …

Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults–update 2004

D Armstrong, JK Marshall, N Chiba… - Canadian Journal of …, 2005 - Wiley Online Library
BACKGROUND: Gastroesophageal reflux disease (GERD) is the most prevalent acid‐
related disorder in Canada and is associated with significant impairment of health‐related …

Healing and relapse of severe peptic esophagitis after treatment with omeprazole

DJ Hetzel, J Dent, WD Reed, FM Narielvala… - Gastroenterology, 1988 - Elsevier
We have studied the response of erosive or ulcerative esophagitis to treatment with
omeprazole and its subsequent relapse on cessation of therapy in 196 patients. In the first …

Ranitidine: an updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases

SM Grant, HD Langtry, RN Brogden - Drugs, 1989 - Springer
Ranitidine, a histamine H 2-receptor antagonist, is now well established as a potent inhibitor
of gastric acid secretion effective in the treatment and prophylaxis of gastrointestinal lesions …

Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease.

NJ Bell, RH Hunt - Gut, 1992 - gut.bmj.com
Gastro-oesophageal reflux disease is a common condition with a complex pathophysiology.
Despite the spectrum of abnormalities, gastric acid has a central role in mucosal damage …

promotility drugs in the treatment of gastro‐oesophageal reflux disease

B Ramirez, JE Richter - Alimentary pharmacology & …, 1993 - Wiley Online Library
Prokinetic agents are drugs that increase contractile force and accelerate intraluminal
transit. They are often used in treating disorders of gastrointestinal motility including gastro …

Гастроэзофагеальная рефлюксная болезнь, резистентная к терапии ингибиторами протонной помпы

ВО Кайбышева, АС Трухманов… - Российский журнал …, 2011 - gastro-j.ru
Гастроэзофагеальная рефлюксная болезнь, резистентная к терапии инг Page 1 Лекции и
обзоры 4 4, 2011 РЖГГК он-лайн – www.gastro-j.ru УДК [616.33-008.17-031:611.329]-085.29 …

Pharmacological management of gastro-oesophageal reflux disease

EC Klinkenberg-Knol, HPM Festen, SGM Meuwissen - Drugs, 1995 - Springer
Gastro-oesophageal reflux disease (GORD) ranges from episodic symptomatic reflux
without oesophagitis to severe oesophageal mucosal damage, such as Barrett's metaplasia …

Prokinetic agents: a key in the future of gastroenterology

JC Reynolds - Gastroenterology Clinics of North America, 1989 - Elsevier
Of the benign diseases affecting the industrialized world, only the common cold exceeds
functional bowel disorders as the foremost cause of absenteeism and indirect health care …

Prokinetic agents

JC Reynolds, PE Putnam - Gastroenterology Clinics of North America, 1992 - Elsevier
Gastrointestinal motility is the extraordinarily complex, highly coordinated neuromuscular
process responsible for movement of luminal contents through the digestive system. Smooth …